Shaheed Zulfiqar Ali Bhutto Medical University/PIMS
Islamabad, 44000, Pakistan
NCT Number: NCT06174584
To see the outcome of results of Cow Milk & Hypertonic Saline in the treatment of Rectal Prolapse in Children
Looking for future studies?
Notify Me1 year–12 year
All sexes
Interventional
Early Phase 1
Islamabad, 44000, Pakistan
Sclerotherapy is the least invasive procedure used in management of grade I/II rectal prolapse, with a success rate of around 80%, and generally considered as the first choice for uncomplicated and recurrent prolapse. Several sclerosing agents such as 15% hypertonic saline, 5% Phenol in almond oil and cow milk have been used and reported in the literature. Present study is designed to determine the efficacy of cow milk and 15% hypertonic saline in the management of children with grade I/II rectal prolapse.
All the details will be entered on the proforma which will include resolvement of rectal prolapse and which agent has adverse effects like recurrence, fecal incontinence and anal stenosis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hypertonic saline
Cow Milk
Time frame: 1 year
Comparison of Cow Milk vs 15% Hypertonic Saline for rectal prolapse
Time frame: 1 year
Comparison of Cow Milk vs 15% Hypertonic Saline for rectal prolapse
Time frame: 1 year
Comparison of Cow Milk vs 15% Hypertonic Saline for rectal prolapse
Shaheed Zulfiqar Ali Bhutto Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06330857
Defecation Disorder, Digestive System Diseases
View Trial DetailsNCT07230275
Digestive System Diseases, Frailty
View Trial DetailsNCT04627610
Digestive System Diseases, Gastrointestinal Diseases
Grenoble, France
View Trial DetailsNCT06353230
Digestive System Diseases, Gastrointestinal Diseases
Lahore, Punjab Province, Pakistan
View Trial Details